(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 256082 - Veritor System Rapid Test Kit SARS-CoV-2 Infectious Disease Immunoassay, Nasal Swab Sample

BD  # 256082 - Veritor System Rapid Test Kit  SARS-CoV-2 Infectious Disease Immunoassay, Nasal Swab Sample
Part Number BD 256082
SKU Number CIA8041325
Sell Unit KIT
Ships Within Special Order
List Price $500.50
Enter a valid quantity
Product Description

BD 256082 - Veritor System Rapid Test Kit SARS-CoV-2 Infectious Disease Immunoassay, Nasal Swab Sample

The BD 256082 Veritor System Rapid Test Kit is a high-performance immunoassay designed for the rapid detection of SARS-CoV-2 antigens using a clinician-collected nasal swab sample. Engineered for use with the BD Veritor Plus Analyzer, this test provides objective, digital results within minutes, supporting faster clinical decision-making in urgent care, outpatient clinics, and point-of-care testing environments. Each kit includes all necessary components for sample collection and analysis, ensuring streamlined workflow and consistent, accurate testing.

Manufacturer256082
ApplicationRespiratory Test Kit
Contents 1(30) Single-use Test Devices, (30) Single-use Reaction Tubes, (30) Sterile Single-use Specimen Sampling Swabs, Positive SARS-CoV-2 Control Swab, Negative SARS-CoV-2 Control Swab, Instructions for Use, Quick Reference Card, Nasal Sampling Instructions
For Use WithFor use with the BD Veritor Plus Analyzer running Firmware version 5.4 or later
Reading TypeMachine Read

Key Benefits

This rapid antigen test delivers fast and reliable detection of active COVID-19 infection, providing results significantly sooner than many laboratory-based assays. The BD Veritor Analyzer eliminates subjective interpretation by producing a digital, easy-to-read result, reducing human error. The nasal swab sample method offers a more comfortable patient experience while maintaining high diagnostic sensitivity. The test is fully CLIA-waived for point-of-care settings, supporting widespread deployment in community healthcare environments.

Compatibility and Applications

The BD 256082 test kit is fully compatible with:

  • BD Veritor Plus Analyzer
  • Clinician-collected anterior nasal swab samples
  • CLIA-waived, moderate-complexity, and laboratory-based settings

Typical clinical applications include:

  • Rapid screening of symptomatic patients
  • Testing in urgent care, primary care, and retail clinics
  • Occupational health screening and return-to-work programs
  • COVID-19 outbreak response and surveillance testing

Usage Guidelines

Collect a nasal swab sample following standard clinical technique. Insert the swab into the reagent tube and mix thoroughly. Transfer the processed sample to the test device and allow it to react for the specified time. Insert the test device into the BD Veritor Plus Analyzer for automated result interpretation. Follow all kit instructions and facility infection-control procedures. Dispose of used materials in approved biohazard containers.

Certifications, Safety Standards, and Regulatory Approvals

This SARS-CoV-2 rapid test is authorized for use under FDA Emergency Use Authorization (EUA) and meets CE and IVD standards for infectious disease diagnostics. It is CLIA-waived when used with the BD Veritor Plus Analyzer in approved settings. Manufacturing follows ISO 9001 and ISO 13485 certified quality systems, ensuring consistent performance, lot-to-lot reliability, and product safety.

Comparison with Competitor Products

Compared with manual antigen tests that rely on visual interpretation, the BD Veritor System offers objective, analyzer-based digital results that greatly reduce interpretation errors. Competitor devices may have more complex workflows or lack automated reading capability. BDs integrated system delivers faster turnaround, simpler operation, and consistent accuracy, making it preferred in high-volume point-of-care environments.

Typical User Profile and Application Scenarios

This test kit is used by:

  • Clinics and urgent care facilities
  • Hospital outpatient departments
  • Pharmacies and retail health centers
  • Schools, workplace health programs, and community testing sites
  • Long-term care facilities and senior health organizations

Best Practices for Use and Maintenance

Store the kits within the recommended temperature range to preserve assay performance. Always use the BD Veritor Plus Analyzer for result interpretation. Do not mix components from different lot numbers. Perform regular quality control checks as required by facility policy. Maintain strict infection-control procedures during sample collection and disposal.

Regulatory and Safety Information

For in vitro diagnostic use only. Authorized under FDA EUA and subject to continued regulatory updates. Not for at-home testing. Single-use componentsdo not reuse. Handle all biological specimens as potentially infectious and follow OSHA and institutional biosafety guidelines.

How to Order

To order the BD 256082 Veritor System SARS-CoV-2 Rapid Test Kit, add the item to your cart and complete checkout through CIA Medicals secure ordering system. For bulk purchasing, supply contracts, or product guidance, contact CIA Medical customer service at (312) 275-5850 or submit an inquiry using the contact form on this page.

Related Products